Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 17.12.2025 FXGB LN IE00BD5HBR05 37,992.00 GBP 732,523.18 25.836 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 17.12.2025 FTFX IE00BD5HBQ97 63,402.00 USD 1,616,688.55 25.499 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF 10% - January 17.12.2025 FJAN.LN IE000MDKBOB3 150,002.00 USD 3,988,802.41 26.592 ...
-
Sandy MacKay Brings Found Spaces Realty Group and Network of 50 Top Ontario Agents to Real
MIAMI--(BUSINESS WIRE)--Top Canadian team leader Sandy MacKay joins Real and brings Found Spaces Realty Group and a 50-agent Ontario network generating $500M annually....
-
Albireo Energy Earns Great Place To Work Certification™ for Eighth Consecutive Year
EDISON, N.J.--(BUSINESS WIRE)--Albireo Energy, a leading independent building controls and energy services provider and Huron Capital portfolio company, has been Certified™ by Great Place To Work® for the eighth year in a row. This award is based on what current employees say about their experience working at Albireo Energy. In 2025, 81% of employees said that Albireo Energy was a Great Place To Work – 24 points higher than the average U.S. company. “This recognition belongs to our employees,”...
-
Owens Corning Names José Méndez-Andino Chief Innovation Officer to Advance Product Leadership and Drive Growth
TOLEDO, Ohio--(BUSINESS WIRE)--Owens Corning (NYSE: OC), a building products leader, today announced that José Méndez-Andino, Ph.D., has been promoted to Executive Vice President and Chief Innovation Officer. This elevated role reflects Owens Corning’s commitment to driving organic growth through innovation, a priority outlined at the company’s 2025 Investor Day and reinforced by its enterprise strategy to leverage unique commercial, operational, and innovation capabilities to create value for...
-
Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) , a clinical-stage breakthrough pharmaceutical company committed to revolutionizing mental healthcare by developing innovative next-generation treatment options, today announced that it will voluntarily transfer its U.S. stock exchange listing to the Nasdaq Global Market (“Nasdaq”) from the NYSE American LLC (“NYSE American”). The Company expects that its common shares will cease trading on the NYSE American at market clos...
-
NMG annonce la fixation du prix du placement public d’actions ordinaires d’un montant de 20 millions $US
MONTRÉAL--(BUSINESS WIRE)--Nouveau Monde Graphite Inc. (« NMG » ou la « Société ») (NYSE: NMG, TSX: NOU) a fixé le prix du placement public de 8 333 334 actions ordinaires de la Société (les « Actions ») annoncé à un prix de 2,40 $US par Action pour un produit brut de 20 millions $US (le « Placement »). Maxim Group LLC agit à titre de seul placeur pour compte dans le cadre du Placement. La Société a l’intention d’utiliser le produit net provenant du Placement pour l’acquisition d’équipements à...
-
NMG Announces Pricing of US$20 Million Public Equity Offering
MONTRÉAL--(BUSINESS WIRE)--Nouveau Monde Graphite Inc. (“NMG” or the “Company”) (NYSE: NMG, TSX: NOU) announces the pricing of a public equity offering of 8,333,334 common shares of the Company (“Shares”) at a price of US$2.40 per Share for gross proceeds of US$20 million (the “Offering”). Maxim Group LLC is acting as sole placement agent for the Offering. The Company intends to use the net proceeds from the Offering for procurement of long-lead equipment, to initiate certain construction activ...
-
Cartography Receives FDA Investigational New Drug (IND) Approval and Fast Track Designation for Lead Program CBI-1214 for Colorectal Cancer
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, Inc., a biotechnology company advancing a differentiated pipeline of antibody-based cancer therapies, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s Investigational New Drug (IND) application for its lead program, CBI-1214. This approval enables Cartography Bio to initiate a Phase I clinical trial for CBI-1214, a T-cell engager being developed for the treatment of colorectal cance...